GT Urological, LLC Awarded SBIR Phase I Grant For Work On Artificial Urinary Sphincters

MINNEAPOLIS--(BUSINESS WIRE)--GT Urological, LLC, a privately held medical device company that develops and markets products for the urinary incontinence market, today announced that it has been awarded a Phase I Small Business Innovation Research (SBIR) grant from the National Institutes of Health (NIH). Gerald W. Timm, Ph.D., GT Urological’s President and co-founder and founder of a number of urological device companies including Mentor Corporation and American Medical Systems is named as the Principal Investigator. “This SBIR Phase I grant will allow GT Urological to study the feasibility of its latest concept for an implantable artificial urinary sphincter,” says Dr. Timm.